<DOC>
	<DOC>NCT03023241</DOC>
	<brief_summary>To identify new, simple and reliable biomarkers for bladder pain syndrome/interstitial cystitis (BPS/IC) for diagnosis of this disease.</brief_summary>
	<brief_title>Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis</brief_title>
	<detailed_description>Collection and analyses of bladder biopsies, bladder washings, blood and urine samples of patients with bladder pain syndrome/interstitial cystitis (BPS/IC), overactive bladder syndrome (OAB) and bladder-healthy controls. Analyses include ELISA, RT-qPCR, DNA sequencing, and immunohistochemistry techniques. Differences between patient groups are statistically evaluated.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis, Interstitial</mesh_term>
	<criteria>patient with diagnosed BPS/IC, OAB or healthy controls included healthy controls must have another pelvic surgery planned (e.g. hysterectomy) being able to act and judge unstable endocrinological situation severe illness</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>BPS/IC</keyword>
	<keyword>OAB</keyword>
</DOC>